Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the

① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.

cls.cnMar 2 21:09 ET

Building a high-frequency communication platform, the "Shanghai Lujiazui Finance & Trade Zone Development Salon" is about to launch with exciting events happening weekly.

① In response to the Shanghai Lujiazui Finance & Trade Zone Development Forum, build an integrated ecosystem of "Global Strategy - Execution." ② The first event on March 1 will focus on "Opportunities and Challenges: Great Power Game, Exchange Rates, and the Construction of the Shanghai International Financial Center."

cls.cnFeb 25 21:24 ET

Investors question when the "dragging out the answer" game will end; when will Shandong Humon Smelting and Jiangxi Copper resolve their competition in the same industry? | Quick read announcement

① The industry competition issue that attracts significant attention from investors has still not made any "substantial" progress; ② Progress is slow, and investors question whether the company is just "playing a delaying game".

cls.cnFeb 10 11:13 ET

Product quantity and price have both declined, coupled with impairments in goodwill and intangible Assets. Guangxi Wuzhou Zhongheng Group expects a loss of 0.2 billion to -0.4 billion yuan in 2024 | Interpretations.

① Guangxi Wuzhou Zhongheng Group released its annual performance forecast for 2024, expecting a net loss of 0.22 billion yuan to -0.43 billion yuan, with the non-recurring net income also expecting a loss of 0.2 billion yuan to -0.4 billion yuan. ② Despite the performance pressure, Guangxi Wuzhou Zhongheng Group simultaneously announced multiple measures to maintain the company's stock price, including stock cancellations, share repurchases, and voluntary locks by major shareholders.

cls.cnJan 24 10:11 ET

Is the industry leader also under pressure? Poly Developments and Holdings Group's performance declines in 2024, initiating structural adjustments.

Poly Developments and Holdings Group recently announced adjustments to its organizational structure, mainly involving the merger of regional companies and personnel changes; before and after this restructuring by Poly Developments and Holdings Group, it coincides with the announcement of a decline in revenue and net profit for 2024.

cls.cnJan 20 05:46 ET

[Data Watch] Institutions and retail investors are engaged in fierce competition for Shenzhen Infogem Technologies as Algo funds rush to buy Recent IPOs.

① The Internet Finance concept stock Shenzhen Infogem Technologies was sold by Institutions for over 60 million, receiving over 0.12 billion in total from two leading speculative trading positions. ② Recent IPOs Tianhe Magnetic Materials received over 80 million from one Algo trading position.

cls.cnJan 14 04:56 ET